Skip to content

13F-HR filed by Financial Advocates Investment Management

Financial Advocates Investment Management filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-13, with 510 holding rows worth $939,161,000.

Accession
0001730293-20-000001
Filed
2020-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2019

A holdings report, 510 entries on the cover page, a total value of $939,161,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $939,161,000 with VALUE read as thousands by filing date, 13F file number 028-18619. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TELEFONAKTIEBOLAGET LM ERICSS ADR B SEK 10294821608ADR10,970$96,000thousands by filing date
MADISON COVERED CALL & EQUITY557437100COM11,150$74,000thousands by filing date
Ohr Pharmaceutical Inc64132K102COM10,000$72,000thousands by filing date
AURORA CANNABIS INC05156X108COMMON STOCK-FO32,612$71,000thousands by filing date
SALARIUS PHARMACEUTICALS INC79400X107COM NEW11,472$43,000thousands by filing date
BRISTOL-MYERS SQUIBB CO110122157RIGHT 99/99/999912,725$39,000thousands by filing date
Jason Industries Inc471172106COMMON STOCK71,460$27,000thousands by filing date
MATINAS BIOPHARMA HLDGS INC576810105COM10,000$23,000thousands by filing date
NABRIVA THERAPEUTICS PLCG63637105SHS13,000$17,000thousands by filing date
VISTAGEN THERAPEUTICS INC92840H202COM23,097$16,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001730293-20-000001this filing2020-02-13acceptance time not in the bulk data set